GlaxoSmithKline Pharma is shifting focus to specialty treatments and preventive healthcare, emphasizing adult vaccines and ...

This report highlights major developments in the health sector, including WeightWatchers offering a new obesity drug, Danco ...

GSK said a dose of its RSV vaccine protected against illness over three years, according to new data presented at the CHEST ...

Cumulatively, data showed the shot to be 63% effective across the three-year period. However, efficacy appeared to wane and GSK said it expects revaccination will eventually be needed.

While recent CDC guidance threatens to shrink the market for a new class of immunizations, GSK continues to build the case ...

Mumbai: A retired GlaxoSmithKline (GSK) employee, Ashok Shetty, on Monday reported a home burglary involving the theft of ...

Millions of people who bought DNA tests from genetic testing service 23andme have been urged to delete their personal data ...

D NA analysis company 23andme has been in trouble lately: data was breached in a 2023 hack, and this September the entire board of directors resigned over disagreements with the C ...

ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries ...

GSK, Sanofi and CSL Ltd have secured $72 million from the US government to ramp up production of bird flu vaccines, Reuters ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

EU regulators are considering withdrawing market authorizations for two hair loss and enlarged prostate treatments over ...